Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future Perspectives.

Shaban E, Bayliss G, Malhotra DK, Shemin D, Wang LJ, Gohh R, Dworkin LD, Gong R.

Kidney Dis (Basel). 2018 Nov;4(4):205-213. doi: 10.1159/000490703. Epub 2018 Jul 31. Review.

2.

The positive effects of an antimicrobial stewardship program targeting outpatient hemodialysis facilities.

D'Agata EMC, Lindberg CC, Lindberg CM, Downham G, Esposito B, Shemin D, Rosen S.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1400-1405. doi: 10.1017/ice.2018.237. Epub 2018 Sep 26.

PMID:
30253815
3.

Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.

D'Agata EMC, Tran D, Bautista J, Shemin D, Grima D.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1389-1397. doi: 10.2215/CJN.12521117. Epub 2018 Aug 23.

PMID:
30139804
4.

Evaluating Infection Prevention Strategies in Out-Patient Dialysis Units Using Agent-Based Modeling.

Wares JR, Lawson B, Shemin D, D'Agata EM.

PLoS One. 2016 May 19;11(5):e0153820. doi: 10.1371/journal.pone.0153820. eCollection 2016.

5.

Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management.

Shemin D.

R I Med J (2013). 2014 Dec 2;97(12):24-7. Review.

PMID:
25463623
6.

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury.

Shemin D, Dworkin LD.

Crit Care Clin. 2011 Apr;27(2):379-89. doi: 10.1016/j.ccc.2010.12.003. Review.

PMID:
21440207
7.

Lupus nephritis mimicking pyelonephritis in pregnancy.

Friedman A, Dailey TL, Shemin D, Anderson BL.

Hypertens Pregnancy. 2010;29(4):478-83. doi: 10.3109/10641950903452378.

PMID:
20701473
8.

Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.

Shemin D, Briggs D, Greenan M.

J Clin Apher. 2007;22(5):270-6.

PMID:
17722046
9.

David Rittenberg.

Shemin D, Bentley R.

Biogr Mem Natl Acad Sci. 2001;80:257-74. No abstract available.

PMID:
15202471
10.

Dialysis in pregnant women with chronic kidney disease.

Shemin D.

Semin Dial. 2003 Sep-Oct;16(5):379-83. Review.

PMID:
12969390
11.

A multicenter, prospective, randomized, comparative evaluation of dual- versus triple-lumen catheters for hemodialysis and apheresis in 485 patients.

Contreras G, Liu PY, Elzinga L, Anger MS, Lee J, Robert N, Chvala R, Mars RL, Vesely T, Taber TE, Shemin D, Shafritz R, Pulliam J.

Am J Kidney Dis. 2003 Aug;42(2):315-24.

PMID:
12900814
12.

Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.

Yango A, Morrissey P, Zanabli A, Beaulieu J, Shemin D, Dworkin L, Monaco A, Gohh R.

Nephrol Dial Transplant. 2003 Apr;18(4):809-13.

PMID:
12637653
13.

The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study.

Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D.

Am J Kidney Dis. 2003 Feb;41(2):442-6.

PMID:
12552508
14.

Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.

Ghandour H, Bagley PJ, Shemin D, Hsu N, Jacques PF, Dworkin L, Bostom AG, Selhub J.

Kidney Int. 2002 Dec;62(6):2246-9.

15.

Prevalence of protein malnutrition in children maintained on peritoneal dialysis.

Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG.

Pediatr Nephrol. 2002 Jul;17(7):527-30. Epub 2002 Jun 11.

PMID:
12172768
16.

Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicators Project.

Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG.

Pediatr Nephrol. 2001 Nov;16(11):854-7.

PMID:
11685588
17.

Treatment of hyperhomocysteinemia in end-stage renal disease.

Shemin D, Bostom AG, Selhub J.

Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S91-4. Review.

PMID:
11576930
18.

Residual renal function and mortality risk in hemodialysis patients.

Shemin D, Bostom AG, Laliberty P, Dworkin LD.

Am J Kidney Dis. 2001 Jul;38(1):85-90.

PMID:
11431186
19.

Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.

Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J.

Kidney Int Suppl. 2001 Feb;78:S246-52.

20.

Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

Yango A, Shemin D, Hsu N, Jacques PF, Dworkin L, Selhub J, Bostom AG.

Kidney Int. 2001 Jan;59(1):324-7.

21.

First hemodialysis access selection varies with patient acuity.

Friedman AL, Walworth C, Meehan C, Wander H, Shemin D, DeSoi W, Kitsen J, Hill C, Lambert C, Mesler D.

Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S4-10.

PMID:
11053581
22.

Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition.

Shemin D, Bostom AG, Lambert C, Hill C, Kitsen J, Kliger AS.

Perit Dial Int. 2000 Jul-Aug;20(4):439-44.

PMID:
11007376
23.

Antihypertensive therapy and progression of chronic renal disease.

Dworkin LD, Shemin DG.

Curr Hypertens Rep. 1999 Oct;1(5):417-22.

PMID:
10981100
24.

Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project.

Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG.

Am J Kidney Dis. 2000 Aug;36(2):310-7.

PMID:
10922309
25.

Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.

Bostom AG, Shemin D, Bagley P, Massy ZA, Zanabli A, Christopher K, Spiegel P, Jacques PF, Dworkin L, Selhub J.

Circulation. 2000 Jun 20;101(24):2829-32. Erratum in: Circulation 2000 Aug 1;102(5):598.

PMID:
10859289
26.

Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients.

Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Jacques PF, Dworkin L, Selhub J.

Transplantation. 2000 May 27;69(10):2128-31.

PMID:
10852611
27.

Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment.

Chodock R, Mylonakis E, Shemin D, Runarsdottir V, Yodice P, Renzi R, Tashima K, Towe C, Rich JD.

Nephrol Dial Transplant. 1999 Oct;14(10):2484-6. No abstract available.

PMID:
10528680
28.

Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.

Shemin D, Maaz D, St Pierre D, Kahn SI, Chazan JA.

Am J Kidney Dis. 1999 Jul;34(1):14-20.

PMID:
10401010
29.

Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.

Shemin D, Lapane KL, Bausserman L, Kanaan E, Kahn S, Dworkin L, Bostom AG.

J Am Soc Nephrol. 1999 May;10(5):1095-9.

30.
31.

Lower fasting total plasma homocysteine levels in stable renal transplant recipients versus maintenance dialysis patients.

Bostom AG, Shemin D, Gohh RY, Verhoef P, Nadeau MR, Bianchi LA, Hopkins-Garcia BJ, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

Transplant Proc. 1998 Feb;30(1):160-2. No abstract available.

PMID:
9474989
32.

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2554-8.

PMID:
9409227
33.

Sodium balance in renal failure.

Shemin D, Dworkin LD.

Curr Opin Nephrol Hypertens. 1997 Mar;6(2):128-32. Review.

PMID:
9146973
34.

Gram negative rod peritonitis in peritoneal dialysis.

Shemin D.

Semin Dial. 1997 Jan-Feb;10(1):38-45. doi: 10.1111/j.1525-139X.1997.tb00458.x. No abstract available.

PMID:
19140863
35.

Gram-negative peritonitis in peritoneal dialysis: improved outcome with intraperitoneal ceftazidime.

Shemin D, Maaz D.

Perit Dial Int. 1996 Nov-Dec;16(6):638-41. No abstract available.

PMID:
8981536
36.

Use of amino acid peritoneal dialysate for one year in a child on CCPD.

Brem AS, Maaz D, Shemin DG, Wolfson M.

Perit Dial Int. 1996 Nov-Dec;16(6):634-6. No abstract available.

PMID:
8981534
37.

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

Bostom AG, Shemin D, Lapane KL, Sutherland P, Nadeau MR, Wilson PW, Yoburn D, Bausserman L, Tofler G, Jacques PF, Selhub J, Rosenberg IH.

Atherosclerosis. 1996 Aug 23;125(1):91-101.

PMID:
8831931
38.

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH.

Atherosclerosis. 1996 Jun;123(1-2):193-202.

PMID:
8782850
39.

Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients.

Bostom AG, Shemin D, Yoburn D, Fisher DH, Nadeau MR, Selhub J.

Atherosclerosis. 1996 Feb;120(1-2):241-4.

PMID:
8645365
40.

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.

Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH.

Kidney Int. 1996 Jan;49(1):147-52.

41.

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW, et al.

Atherosclerosis. 1995 Apr 7;114(1):93-103.

PMID:
7605381
42.
43.

Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation.

Bostom AG, Shemin D, Nadeau MR, Shih V, Stabler SP, Allen RH, Selhub J.

Atherosclerosis. 1995 Feb;113(1):129-32. No abstract available.

PMID:
7755649
44.

Renal osteodystrophy and dialysis artifacts as indicators of identification.

London MR, Libbey NP, Shemin DG, Chazan JA.

Forensic Sci Int. 1994 Mar 25;65(2):81-96.

PMID:
8206460
45.

Serum creatinine concentration at the onset of uremia: higher levels in black males.

Abuelo JG, Shemin D, Chazan JA.

Clin Nephrol. 1992 Jun;37(6):303-7.

PMID:
1638782
46.

Abnormalities of lipoprotein metabolism in the nephrotic syndrome.

Bostom AG, Shemin D.

N Engl J Med. 1991 Mar 7;324(10):697-8. No abstract available. Erratum in: N Engl J Med 1991 May 9;324(19):1380.

PMID:
1994257
47.

Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure.

Shemin D, Cohn PS, Zipin SB.

Arch Intern Med. 1990 Nov;150(11):2384-5.

PMID:
2241450
48.

Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure.

Shemin D, Elnour M, Amarantes B, Abuelo JG, Chazan JA.

Am J Med. 1990 Oct;89(4):436-40.

PMID:
2171332
49.

Acute renal failure in pregnancy. Management depends upon cause, but dialysis may be necessary.

Shemin D, Chazan JA.

R I Med J. 1989 Apr;72(4):125-7. Review. No abstract available.

PMID:
2657982
50.

A risk factor for AIDS nephropathy.

Shemin D, Chazan JA.

Nephron. 1989;51(4):558. No abstract available.

Supplemental Content

Loading ...
Support Center